The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real-world outcomes in patients with metastatic renal cell carcinoma treated with first-line nivolumab plus ipilimumab.
 
Gurjyot K. Doshi
Consulting or Advisory Role - Janssen Biotech
 
Nicholas J. Robert
Employment - McKesson
Leadership - McKesson
Stock and Other Ownership Interests - Johnson & Johnson (I); McKesson; Oncolytics (I)
Honoraria - Bristol-Myers Squibb; Roche
Consulting or Advisory Role - Advi; Boehringer Ingelheim; Bristol-Myers Squibb; New Century Health
 
Liwei Chen
No Relationships to Disclose
 
Philip K Chan
Employment - IBM; Ontada/McKesson
Stock and Other Ownership Interests - Abbott; AstraZeneca; IBM; Inovio Pharmaceuticals; McKesson; Pfizer
 
Viviana Del Tejo
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Brian Stwalley
Employment - Bristol-Myers Squibb; Sunovion (I)
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Stephen Huo
Employment - Bristol Myers Squibb
Stock and Other Ownership Interests - Bristol Myers Squibb
 
Daniel M. Geynisman
Consulting or Advisory Role - 2nd.MD; AstraZeneca; Eisai; Exelixis; Merck; Myovant Sciences; Pfizer; Seattle Genetics/Astellas
Research Funding - Astellas Pharma (Inst); Calithera Biosciences (Inst); Genentech (Inst); Harpoon therapeutics (Inst); Merck (Inst)